Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
Breast Cancer Research · 01.01.2012
DOI: 10.7916/d8qr4vg8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research, erschienen am 01.01.2012. Verfasst von Antoniou und 59 weiteren Autor:innen.
Abstract (Originalsprache)
Several common alleles have been shown to be associated with breast and/or ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Recent genome-wide association studies of breast cancer have identified eight additional breast cancer susceptibility loci: rs1011970 (9p21, CDKN2A/B), rs10995190 (ZNF365), rs704010 (ZMIZ1), rs2380205 (10p15), rs614367 (11q13), rs1292011 (12q24), rs10771399 (12p11 near PTHLH) and rs865686 (9q31.2). To evaluate whether these single nucleotide polymorphisms (SNPs) are associated with breast cancer risk for BRCA1 and BRCA2 carriers, we genotyped these SNPs in 12,599 BRCA1 and 7,132 BRCA2 mutation carriers and analysed the associations with breast cancer risk within a retrospective likelihood framework. Only SNP rs10771399 near PTHLH was associated with breast cancer risk for BRCA1 mutation carriers (per-allele hazard ratio (HR) = 0.87, 95% CI: 0.81 to 0.94, P-trend = 3 × 10-4). The association was restricted to mutations proven or predicted to lead to absence of protein expression (HR = 0.82, 95% CI: 0.74 to 0.90, P-trend = 3.1 × 10-5, P-difference = 0.03). Four SNPs were associated with the risk of breast cancer for BRCA2 mutation carriers: rs10995190, P-trend = 0.015; rs1011970, P-trend = 0.048; rs865686, 2df-P = 0.007; rs1292011 2df-P = 0.03. rs10771399 (PTHLH) was predominantly associated with estrogen receptor (ER)-negative breast cancer for BRCA1 mutation carriers (HR = 0.81, 95% CI: 0.74 to 0.90, P-trend = 4 × 10-5) and there was marginal evidence of association with ER-negative breast cancer for BRCA2 mutation carriers (HR = 0.78, 95% CI: 0.62 to 1.00, P-trend = 0.049). The present findings, in combination with previously identified modifiers of risk, will ultimately lead to more accurate risk prediction and an improved understanding of the disease etiology in BRCA1 and BRCA2 mutation carriers.
Schlagwörter
Zitieren
APA
Antoniou, Antonis, Kuchenbaecker, K. B., Soucy, Penny, Beesley, Jonathan, Chen, Xiaoqing, McGuffog, Lesley, Lee, Andrew, Barrowdale, D., Healey, S., Sinilnikova, O. M., Caligo, Maria, Loman, …, & Juul (2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research. https://doi.org/10.7916/d8qr4vg8
Vancouver
Antoniou, Antonis, Kuchenbaecker KB, Soucy, Penny, Beesley, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research. 2012. doi:10.7916/d8qr4vg8
BibTeX
@article{Antoniou2012,
author = {Antoniou and Antonis and Kuchenbaecker, Karoline B. and Soucy and Penny and Beesley and Jonathan and Chen and Xiaoqing and McGuffog and Lesley and Lee and Andrew and Barrowdale, Daniel and Healey, Sue and Sinilnikova, Olga M. and Caligo and Maria and Loman and Niklas and Harbst, Katja and Lindblom and Annika and Arver and Brita and Rosenquist and Richard and Karlsson and Per and Nathanson and Kate and Domchek and Susan and Rebbeck and Tim and Jakubowska, Anna and Lubinski and Jan and Jaworska, Katarzyna and Durda and Katarzyna and Złowocka-Perłowska, Elżbieta and Osorio and Ana and Durán and Mercedes and Andrés and Raquel and Benítez and Javier and Hamann and Ute and Hogervorst and Frans and Os, Theo A.M. van and Verhoef and Senno and Meijers-Heijboer, Hanne E.J. and Wijnen and Juul},
title = {Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers},
journal = {Breast Cancer Research},
year = {2012},
doi = {10.7916/d8qr4vg8}
}
EUVIMED